Bharat Parenterals Limited (NSE:BPLPHARMA)

Bharat Parenterals Revenue

Bharat Parenterals had revenue of 1.36B INR in the quarter ending September 30, 2026, with 110.90% growth. This brings the company's total for the last twelve months to 3.95B, up 10.64% year-over-year. In the fiscal year ending March 31, 2026, Bharat Parenterals had annual revenue of 3.45B with 1.48% growth.

• Revenue (ttm): 3.95B
• Revenue Growth: +10.64%
• P/S Ratio: 3.17
• Revenue / Employee: 9.77M
• Employees: 404
• Market Cap: 12.50B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Manufacturing Of Pharma Products 2.11B 61.1%
• Contract Development And Manufacturing Operations 723.09M 20.9%
• Trading Of Pharma Products 621.57M 18.0%

By Geography

Chart

• India 1.96B 72.3%
• Outside India 748.97M 27.7%

Fiscal year ended Mar 31, 2026 See the full Bharat Parenterals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	3.45B	50.49M	1.48%
Mar 31, 2025	3.40B	791.65M	30.31%
Mar 31, 2024	2.61B	419.14M	19.11%
Mar 31, 2023	2.19B	69.72M	3.28%
Mar 31, 2022	2.12B	51.08M	2.46%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error